The enzyme 5.1O-methenyltetrahydrofolate synthetase catalyzes the key enzymatic reaction in the pathway by which 5-formyl tetrahydrofolate (leucovorin) enters the folate coenzyme pool. The distribution of this enzyme in different organs and tumor cell lines was studied. This enzyme has a wide distribution among organs and tumor cell lines with highest levels of activity in liver and kidney. Tumor cell lines also contain significant levels of this enzyme activity. Thus, leucovorin can be converted to active folate coenzyme forms in organs and tumor cells, and does not require conversion in liver alone. The implications of these findings for leucovorin usage as "rescue" after methotrexate treatment or to augment fluoropyrimidine cytotoxicity are discussed.
Introduction 5,10-methenyltetrahydrofolate synthetase (methenyl THFS) converts [65] 5-formyltetrahydrofolate (leucovorin. LV, folinic acid) to 5,1 O-methenyltetrahydrofolate (methenyl THF) in the presence of Mg-and ATP (1) . LV is used clinically as a rescue agent following administration of high doses of methotrexate (MTX) (2) and to enhance 5-fluoropyrimidine cytotoxicity in chemotherapy (3). The reaction catalyzed by methenyl THFS is considered to be the key step in the major pathway by which LV enters the folatecoenzyme pool and exerts its pharmacological function. Because of its important role in the chemotherapy regimes utilizing LV, the enzyme has been purified and characterized from L. casei, rabbit liver and human liver (4, 5.6) .
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Copyright «:' 1991 Walter de Gruyter . Berlin· New York determined . It is generally assumed that the liver is the organ responsible for converting LV into active folate derivatives. which circulate in the blood stream to supply other tissues. Data on the activity of this enzyme in tumor cells are also lacking. We studied the tissue distribution of methenyl THFS in rats and found that other organs, besides liver, had appreciable enzyme activit y. All of the tumor cell lines examined contain this enzyme activity as well.
Material and Methods

Chemicals
The following were obtained from indicated commercial sources: Tissue and cell line preparation Rats (male, CDF) 200-300 g, were sacrificed by ether overdose. After dissection, the organs except bone marrow were washed with cold saline; blotted, weighed, and homogenized in cold homogenization buffer (20 mM BES , 20 mM 2-mercaptoethanol, 10 mM magnesium acetate, 0.1 mM PMSF, pH 7.0). The homogenates were centrifuged at 13000 x g, 4 · C for 30 minutes; and the supernatants were frozen at -20 C or used fresh for enzyme activity measurement. The supernatant of rat liver was further fraetioned with ammonium sulfate and the 40% -70% fraction was dialysed overnight at 4C in dialysis buffer (20 mM BES, 20 mM 2-mercaptoethanol , 10 mM magnesium acetate, 0.1 ' Yo Tween, 10°/c, glycerin pH 7.0) for kinetic studies . Bone marrow obtained from femurs of 2 -3 rats was pooled, washed with cold PBS and after frecze-thawing three times in the homogenization buffer, was centrifuged as above and the 40% -70% ammonium sulfate precipitation fraction was collected and dialysed as above. Ten rats were used in the study.
The following tumor cell lines were examined: a cloned subline of the human T-lymphoblast cell line, CEM (8) , and its MTX resistant subline with an altered polyglutamate synthetase, CEM / P (9); a Chinese hamster ovary cell line, CHO (10) , and a MTX resistant subline with an amplified and altered dihydrofolate reductase, CHOI R (11); a cloned rat sarcoma cell line induced by 3-methylcholanthrene (12, 13); a cloned subline of the human colon tumor cell line HCT-8 (14) .
All the cell lines were grown in a RPMJ 1640 supplemented with 10% fetal bovine serum, penicillin (100 units/ml), and streptomycin (100 J..lgjml) at 37 'C in a 5% CO 2 atmosphere.
Tumor cells (1O~ -10'!) were harvested and washed with PBS, frozen and thawed three times in the homogenization buffer and were centrifuged as above. Supernatants were concentrated through a centricon-10 fi Iter.
Enzyme assay
The reaction is followed by the increase of absorbance at 360 nm essentially as described by Hopkins and Schirch (5). The complete reaction mixture contained: 50 mM MES, 0.2 mM [6R,S] LV, 5 mM ATP, 10 mM magnesium acetate, 10 mM 2-mercaptoethanoL pH 6.0, in a total volume of 1 ml (5). The molar absorptivity coefficient of methenyl THF is 25000 M I cm I (8) . One unit of activity is defined as 1 J..lmol of product formed per min at 30 C, and specific activity is High performance liquid chromatography (HPLC) with an adsorbosphere phenyl column (4.6 x 250 mm) and pre-column (4.6 x 10 mm) was used to characterize the products of the enzyme reaction. The mobile phase was 10 mmol / L ammonium dibasic phosphate pH 5.0 and 5% methanol: the flow rate was 1 ml !min; the column temperature was maintained at 4C; the injection volume was 20 J..lL; and the chromatography was monitored for 15 min. The enzyme used in this study was purified from rabbit liver acetone powder by folinic sepharose and blue agarose affinity chromatography as described by Bertrand et al with some modifications (6) . Methenyl THF ws synthesized as a standard by acidifying 0.2 mM [6R,Sl LV with 6N HC!.
Kinetic parameters of the rat liver enzyme were determined by varying either ATP or LV concentration in the reaction mixture mentioned above. All the enzyme reaction assays were performed in duplicate or triplicate.
Protein assay
Protein concentration was determined using the BioRad dye binding assay with bovine serum albumin as standard.
Results
Analysis of product formation
The reaction catalyzed by methenyl THFS is conveniently followed by the increase in absorbance at 360 nm due to the formation of methenyl THF. To verify the products formed, HPLC was used to follow the course of the enzyme reaction (Fig. 1) . The following elution times were observed: ATP at 2.7 min, 2-mercaptoethanol at 4.3 min . The peak at 9.2 min was identified as methenyl THE using the synthetic methenyl THF as a standard .
Tissue distribution of methenyl THFS in the rat
The tissue extracts were prepared as described 111 Material and Methods and the extracts were tested for methenyl THFS activity. The enzyme activities obtained in different rat tissues are listed in Table 1 . The liver contained the highest amount of enzyme and the highest specific activity. Enzyme activity was also detected in kidney, bone marrow, intestine and testes. The kinetic parameters of the rat liver enzyme T he ti ss ues obtained from rat were prepa red a nd the enzy me rcactio n was perform ed o n the tissue ho mogena te supernata n t fraction as discussed in Ma terial and M ethods. Te n ra ts were used in the assay.
Ta ble I . T issue distribution of methenyl T H FS
* Activity of 40 -70 % ammonium sulfa te fraction . 
The Km va lues were d eterm ined by va rying either ATP or LV co ncentra tion s in the reac tio n mi xture.
p repared by ammonium sulfate fra ctionation were compared with data obta ined fro m other sources (Table 2). The rat liver enzyme has similar Km va lues for LV and ATP as the human liver enzyme.
Activi ty of the methenyl T H FS in tumor ce ll lin es
A human T -Iymphoblast cell line CEM and its M T X resista n t subline with an altered polyglutamate synthet ase, CEM /P, human colon tumor cell line, H CT-8, a Chinese hamster ovary cell li ne, CHO, a nd its MTX resistan t subline, CHOI R, and a cloned rat The cell lines were grown in RPM! supplem ented media . 10"-10') cells were used fo r prepa ration of extracts as d escribed in Material and Metho ds. Data are expressed as the average 0 1' 3 en7.yme assays.
sarcoma cell line were tested for mcthenyl TH FS activity (Table 3) . HCT-8 cell contains the highest level of enzyme activity. while the sarcoma cell line had the lowest activity. There is no significant difference in the levels of the enzyme activity between CEM and CEM /P. or between the CHO and CHaR cell line.
Discussion
LV is used in the clinic to rescue normal bone marrow and intestinal cells from the toxic effects of MTX. and more recently in combination with 5-tluorouracil (FUra) or S-fluorodeoxyuridine (FdUrd) to increase the antitumor effects of these drugs by increasing intracellular levels of methylene THF polyglutamates.
A mixture of the natural [6S] LV and the unnatural [6 R] LV isomers is employed, and studies to date have shown that the unnatural isomer does not interfere with the actions of the natural diastereomer. Of interest is the finding that the rat liver methenyl THFS enzyme also is specific for [6S]-LV (15) . The Km for LV was similar to the value reported for the human enzyme (6) . The Km for ATP may be lower than measured, since the determination was done with crude extract.
Effective rescue by LV from MTX toxicity requires that LV is taken up by bone marrow and intestinal stem cells, and is converted to other folate coenzymes. Alternatively LV may be converted to 5-methyl THF only in liver, and this latter coenzyme transported and utilized by marrow and intestine. This study shows that methenyl THFS is present in other organs in addition to the liver, and thus these tissues are capable of utilizing LV directly, although the liver would appear to be the major site of LV metabolism when organ mass is considered. The relative contribution of each of these folate coenzymes in the rescue of these normal tissues as well as their utilization by the relevant tumor would now be important to assess in order to understand the selectivity of high dose MTX-LV rescue programs . The presence of this enzyme activity in all of the tumor cell lines tested indicates that tumor cells are also capable of metabolizing LV. However, the level of activity observed differed by more than 3 fold. Tumor cells with low levels of this enzyme (and perhaps methionine synthetase which convert S-methyl THF to THF), may be less likely to be rescued by LV after high dose MTX regimens. It will be of interest to measure these enzyme activities in osteosarcoma cells, since high dose MTX-LV has
been reported to be effective in the treatment of this tumor (16) . Of interest is the recent report that in a mouse tumor, colon # 38, refractory to potentiation of FU ra by LV, the level of methenyl THFS was low, and LV taken up by this tumor in vivo was not converted to other folate coenzymes (17) . The CEM j P cell line is also refractory to potentiation of FUra by LV, but in this case this appears to be due to the defect in polyglutamate formation, which allows LV and methenyl THF to be retained inside the ceiL rather than a low methenyl THFS activity (18) .
Determination of the rise in intracellular folate coenzymes after LV administration may be useful to predict whether or not a given tumor would be selectively killed by high dose MTX regimens (little or no increase in intracellular folates, especially folate polyglutamates) or by FUra plus high dose LV (an increase in methylene THF polyglutamates). These measurements require tumor sampling after LV dosing, and require several days to perform. Alternatively, based on these and other studies, the measurement ofmethenyl THFS, methionine synthetase, and folyl polyglutamate synthetase levels may provide similar information.
